EXACT Sciences Corp

• Personalized Diagnostic Medicine Coming of Age

  By Streetwise Reports - December 6, 2012 | Tickers: EXAS, GHDX, OPK

  By George S. Mack of The Life Sciences Report.

  For more interviews with sector experts and analysts, please sign up for our newsletter at www.thelifesciencesreport.com.

  As little as a decade ago we were all thinking in terms of one blood draw being the be-all and end-all of diagnostics. With the first human genome sequenced, it would only require a panel of genetic, epigenetic, proteomic and small molecule metabolic more »

• 12 Stocks to Buy and Forget for 2012

  By Kirk Spano - December 27, 2011 | Tickers: APA, AMAT, BRK-B, DISH, EXAS, GE, GMO, KSS, MRK, MON, BTU, SPWR

  If you hold one stock in your portfolio, you carry 100% of the risk of losing all of your money.  As you diversify your holdings from one company to two to three, you are gradually reducing your risk of losing everything. We all know this. What most investors don’t know is that a 12 stock portfolio of domestic companies cuts your company specific risk about 90%.  There are some pretty strong arguments for owning these dozen stocks in your portfolio in 2012.

• 2 Biospecs With Huge Upside for 2012

  By Kirk Spano - December 20, 2011 | Tickers: CRME, EXAS, MRK

  Tis the season for picking the stocks that might provide a bag load of profits for you.  And no other sector screams speculative fortunes than biotech.  What we have today are two companies, while far away from being sure things, offer shots at the elusive ten-bagger.